Filter options:

Freebase Commons Common /common

  • Peginterferon alfa-2a injectable solution, for subcutaneous administration, consisting of: 0.27mg/mL peginterferon alfa-2a.Indications:PEGASYS is an antiviral indicated for: Treatment of Chronic Hepatitis C (CHC) in patients 5 years of age and older with compensated liver disease not previously treated with interferon alpha, in patients with histological evidence of cirrhosis and compensated liver disease, and in adults with CHC/HIV coinfection and CD4 count greater than 100 cells/mm3 (1.1) Combination therapy with COPEGUS is recommended unless patient has contraindication to or significant intolerance to COPEGUS (1.1) PEGASYS monotherapy is indicated for: Treatment of adult patients with HBeAg positive and HBeAg negative chronic hepatitis B infection who have compensated liver disease and evidence of viral replication and liver inflammation (1.2)

Freebase Commons Medicine /medicine

Strength value Strength units Active ingredient Drug formulations available in this strength
  • mg/mL
  • -